Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on RTC GROUP PLC. We currently have 5 research reports from 2 professional analysts.
|17Mar17 07:00||RNS||Grant of Share Options|
|27Feb17 07:00||RNS||Final results for the year ended 31 December 2016|
|07Feb17 15:27||RNS||TR-1: Notification of Major Interest in Shares|
|27Jan17 08:24||RNS||TR-1: Notification of major interest in shares|
|27Jan17 08:18||RNS||Trading update and notice of results|
|03Jan17 07:00||RNS||Change of Advisers|
|02Nov16 08:41||RNS||Holding(s) in Company|
Frequency of research reports
Research reports on
RTC GROUP PLC
RTC GROUP PLC
2017 PER of 7x and a dividend yield of 7%
08 Mar 17
There are numerous reasons to buy RTC. Improved visibility due to its exposure to recurring, higher margin, contracts in the robust UK engineering sector now account for c46% of revenues – up from 25% in 2014. Following a strong start to 2017 we forecast adjusted PBT growth of 16%, a ROCE of 19% and a sustainable dividend and FCF yield of 7% and 11% respectively. With a PE rating of just 7x we initiate with a BUY recommendation and a price target of 85p, representing 73% upside.
Small Cap Breakfast
27 Jan 17
Rainbow Rare Earths has published a prospectus. It has raised $8m to fast-track fully permitted high grade Gakara ‘rare earths’ project to production in Burundi. Intends to join the Standard List of the LSE. Impact healthcare REIT— Intends to float on the main market. Seeks to raise £160m to acquire a portfolio of up to 58 care homes. Expected Admission 7 March. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
Hybridan - Small Cap Wrap
04 Mar 15
FOUR Final results, BNK Settlement of Lawsuit, BDI Contract Win, CAZA $4m Convertible Loan, CGNR* Interims, CHAR 2D Seismic Programme , CLIN Adds New Program, CNC Product Launch, FITB* Appeal and Integration with Samsung, IMTK Contracts win, Herschel heaters connected by LWRF, MARL* Equity Raising, Conversion and Drilling Update, MWE Financial Results, OPTI* Board Appointment, PEG* Contract Win, ROL Acquisition, RTC Network Rail award, SAR* Interims and Research Update, SND AGM Statement, TPET Placement
N+1 Singer - Morning Song 21-03-2017
21 Mar 17
accesso Technology (ACSO LN) Full year results in line, but key trading months still ahead | Augean (AUG LN) Double digit growth in ’16, good start to ‘17 | Earthport (EPO LN) Interims show continued top line strength | Goals Soccer Centres (GOAL LN) Good momentum under new team. It’s now all about delivery | IQE (IQE LN) FY’16 results prompt further upgrades | Microsaic Systems (MSYS LN) Challenges in 2016, strategy remains in place | mporium Group (MPM LN) Funds raised to help execute strategy | RhythmOne (RTHM LN) Dawn of the independents | ScS Group (SCS LN) Strong progress on key growth initiatives albeit comps now toughen | Sinclair Pharma (SPH LN) FY results: EBITDA ahead, Instalift™ gaining pace | Vectura Group (VEC LN) FY (9-month) results
N+1 Singer - Augean - Double digit growth in ’16, good start to ‘17
21 Mar 17
Augean reported another year of double digit growth for 2016, with profits in line with our forecasts. Sales grew by 21% excluding landfill tax, while adjusted PBT grew by 18% to £7.1m before amortisation of acquired intangibles. DPS was increased by 54% to 1.0p, 25% ahead of our estimate. The business units made further strategic progress, with revenues from their top 20 customers increasing from 42% to 43% of the total, of which 88% was under contract or a framework agreement, increasing forward visibility. There has been an encouraging start to 2017 and management is confident of delivering another year of profits growth. The shares trade on undemanding single digit multiples, offering good value.